Nature Reviews Cancer is a monthly review journal for researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.
https://www.nature.com/nrc/
Nature Reviews Cancer
Loading...
In this #ToolsoftheTrade article, Guangqing Lu describes the development and use of cytokine cellular locating platforms (CyCLoPs), a technology that enables visualization and tracking of cytokine signalling in vivo.
📖 👇
#JournalClub🚨
Stephenson-Gussinye & Furlan-Magaril explore how 3D genome reorganization explains why only some variants drive gene expression changes in cancer
📖👇
#ResearchHIghlight 🚨
Hu et al. show extracellular vesicles (#EVs) from activated T cells enhance antigen presentation in tumour cells and dendritic cells, promoting immune-mediated tumour clearance
📖👇
#Research Highlight🚨
New research shows the heart's resistance to tumor formation is influenced by mechanical load. Cardiac contractions activate a mechano-epigenetic pathway that suppresses cancer cell proliferation in vivo and in engineered heart tissues. 📖👇
dlvr.it/TSlM5m
Our JUNE issue is now live! ☀️🍉
It features #REVIEWs on:
- Balancing type I interferon signalling
- Interplay between steatotic liver disease and liver cancer
- KMT2C/KMT2D-COMPASS complex loss in cancer
- #ExpertRecommendation on ovarian cancer
📖👇
http://dlvr.it/TSrBnm
In case you missed this #JournalClub🚨
Terrazas&Peón discuss a recurrent CTNNB1 mutation generating public #neoantigens recognized by engineered #TCRTcells, enabling potent antitumour responses across models
📖👇
Rare cancers remain underserved by precision oncology. In this #Comment, the authors propose that systematic, variant-level pharmacological mapping of approved kinase inhibitors can transform this gap into an opportunity for scalable drug repurposing.
📖 👇
